Shanghai Haohai Biological Technology Purchases Full Stake in Lens Maker

MT Newswires Live

11/10

Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in Shenzhen New Industries Material of Ophthalmology from its sellers, according to a Monday filing with the Shanghai bourse.

Sellers Shenzhen Baina Tongda Investment Consulting Partnership, Shenzhen Jiusi Investment Partnership and Shenzhen New Industries Material of Ophthalmology director Zhang Jinsong sold the stake for 74 million yuan.

Once the acquisition is completed, Haohai will hold 100% in the lens manufacturer.

Shares rose 2% in Shanghai during afternoon trading on Monday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2582448188"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582448188\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582448188?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 14:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582448188","market":"hk","top_or_hot":-1,"title":"Shanghai Haohai Biological Technology Purchases Full Stake in Lens Maker","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in <a href=\"https://laohu8.com/S/300832\">Shenzhen New</a> Industries Material of Ophthalmology from its sellers, according to a Monday filing with the Shanghai bourse.</p><p>Sellers Shenzhen Baina Tongda Investment Consulting Partnership, Shenzhen Jiusi Investment Partnership and Shenzhen New Industries Material of Ophthalmology director Zhang Jinsong sold the stake for 74 million yuan.</p><p>Once the acquisition is completed, Haohai will hold 100% in the lens manufacturer.</p><p>Shares rose 2% in Shanghai during afternoon trading on Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Haohai Biological Technology Purchases Full Stake in Lens Maker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Haohai Biological Technology Purchases Full Stake in Lens Maker\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-10 14:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SHBTF\">Shanghai Haohai Biological</a> Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in <a href=\"https://laohu8.com/S/300832\">Shenzhen New</a> Industries Material of Ophthalmology from its sellers, according to a Monday filing with the Shanghai bourse.</p><p>Sellers Shenzhen Baina Tongda Investment Consulting Partnership, Shenzhen Jiusi Investment Partnership and Shenzhen New Industries Material of Ophthalmology director Zhang Jinsong sold the stake for 74 million yuan.</p><p>Once the acquisition is completed, Haohai will hold 100% in the lens manufacturer.</p><p>Shares rose 2% in Shanghai during afternoon trading on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06613","symbol_name":"蓝思科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2582448188","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582448188","pubTimestamp":1762755029,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in Shenzhen New Industries Material of Ophthalm","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688366":"昊海生科","06613":"蓝思科技","BK1161":"生物科技","BK1593":"医美概念股","06826":"昊海生物科技","BK0251":"专用设备","BK1170":"电子元件","BK0239":"医药制造"},"translate_title":"上海昊海生物科技收购镜片制造商全部股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688366":0.9,"06613":1.5,"06826":0.9},"content_text":"Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in Shenzhen New Industries Material of Ophthalmology from its sellers, according to a Monday filing with the Shanghai bourse.Sellers Shenzhen Baina Tongda Investment Consulting Partnership, Shenzhen Jiusi Investment Partnership and Shenzhen New Industries Material of Ophthalmology director Zhang Jinsong sold the stake for 74 million yuan.Once the acquisition is completed, Haohai will hold 100% in the lens manufacturer.Shares rose 2% in Shanghai during afternoon trading on Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}